ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Clinical trial NCT05671510 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05671510
Sponsor: OncoC4, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2023-06-28
Primary completion: 2027-08-31
Enrollment: 630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.